News | September 30, 2007

3D Multilayer Stent System Treats Popliteal Aneurysm Patient

October 1, 2007 - Cardiatis SA announced today that physicians performed the first reportedly successful treatment of a popliteal aneurysm patient with the Cardiatis FluidSmart 3D Multilayer Braided Stent, an investigational device in the European Union, which is a next generation technology for endovascular aneurysm repair.

The procedure was performed by Professor Antonios Polydorou at Agios Panteleimon General Hospital of Nikaia in Athens, Greece. The first treated patient, a 75-year old male, on December 14th 2006 underwent a minimally invasive endovascular procedure that placed a Cardiatis FluidSmart hemodynamic modulating stent to treat a 5 cm popliteal aneurysm. Post procedural angiogram showed successful deployment and reduction in flow within aneurysm.

On February 20th 2007, two months following stent implantation, angiography revealed the formation of an organized thrombus within the aneurysm with reduction in aneurysm size.

On July 10th, 2007 the seven-month follow up angiogram revealed complete exclusion of aneurysm from circulation. As of the time of writing, the aneurysm remains excluded from circulation with no recanalization and the patient has resumed full functionality.

For more information: www.cardiatis.com


Additional Content

News | Stent Grafts

Oct. 14, 2026 — W. L. Gore & Associates' medical business has announced U.S. Food and Drug Administration approval of an ...

Home October 14, 2026
Home
News | Stent Grafts

April 26, 2023 — Medtronic today announced its Endurant abdominal aortic aneurysm (AAA) stent graft system continues to ...

Home April 26, 2023
Home
News | Stent Grafts

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

Home January 12, 2023
Home
News | Stent Grafts
May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac ...
Home May 04, 2022
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
Subscribe Now